Gerald I Shulman, MD, PhD, FACP, FACE

George R. Cowgill Professor of Medicine (Endocrinology) and Professor of Cellular and Molecular Physiology; Investigator, Howard Hughes Medical Institute; Co-Director, Yale Diabetes Research Center; Director, Yale Mouse Metabolic Phenotyping Center

Departments & Organizations

Cellular & Molecular Physiology: Epithelial Transport of Ions and Solutes | Graduate Program in Cellular and Molecular Physiology | Organ Physiology | Physiology and Integrative Medical Biology Track | Physiology of Human Disease

Center for X-Linked Hypophosphatemia, Yale

Internal Medicine: Diabetes Research Center | Endocrinology: Diabetes Center; Fellowship Training

Mouse Metabolic Phenotyping Center

Office of Student Research

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Biography

Dr. Shulman is Professor of Internal Medicine & Cellular and Molecular Physiology at Yale University, where he serves as Associate Director of the Yale Diabetes Endocrine Research Center and Associate Director of the Yale Medical Scientist (M.D., Ph.D.) Program. He is also an Investigator of the Howard Hughes Medical Institute. Dr. Shulman is an internationally recognized diabetes researcher, and the recipient of numerous awards, including the Outstanding Scientific Achievement Award and the Distinguished Clinical Scientist Award from the American Diabetes Association, the Diabetes Care Research Award from Boehringer-Mannheim/Juvenile Diabetes Foundation, and the Stanley Korsmeyer Award from the American Society for Clinical Investigation (ASCI). In addition to the ASCI Dr. Shulman is a Fellow of the American Association for the Advancement of Science and he has been elected to the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine and the National Academy of Sciences. He is a leading authority on the cellular mechanisms of insulin resistance, the role of the liver and muscle in the pathogenesis of type 2 diabetes, and the benefits of exercise in the management of diabetes. Dr. Shulman's practice is limited to the treatment of diabetes, and other disorders of glucose metabolism, with specific interests in the management of newly diagnosed type 2 diabetes mellitus.

Education & Training

MD Wayne State University (1979)
PhD Wayne State University (1979)
BS University of Michigan, Ann Arbor, MI (1974)
Fellow Massachusetts General Hospital/Harvard Medical School
Resident Duke University Medical Center
Fellow Yale University School of Medicine

Edit this profile